These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16301665)

  • 1. Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.
    Venkataraman N; Cole AL; Svoboda P; Pohl J; Cole AM
    J Immunol; 2005 Dec; 175(11):7560-7. PubMed ID: 16301665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense.
    Cole AM; Cole AL
    Am J Reprod Immunol; 2008 Jan; 59(1):27-34. PubMed ID: 18154593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.
    Cole AM; Cole AL
    Viruses; 2017 May; 9(5):. PubMed ID: 28505117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic polypeptides are required for antibacterial activity of human airway fluid.
    Cole AM; Liao HI; Stuchlik O; Tilan J; Pohl J; Ganz T
    J Immunol; 2002 Dec; 169(12):6985-91. PubMed ID: 12471133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma.
    Martellini JA; Cole AL; Venkataraman N; Quinn GA; Svoboda P; Gangrade BK; Pohl J; Sørensen OE; Cole AM
    FASEB J; 2009 Oct; 23(10):3609-18. PubMed ID: 19487309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.
    Tyssen D; Wang YY; Hayward JA; Agius PA; DeLong K; Aldunate M; Ravel J; Moench TR; Cone RA; Tachedjian G
    mSphere; 2018 Jul; 3(4):. PubMed ID: 29976641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa.
    Cole AL; Cole AM
    Antibiotics (Basel); 2014 Nov; 3(4):677-93. PubMed ID: 27025760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate host defense of human vaginal and cervical mucosae.
    Cole AM
    Curr Top Microbiol Immunol; 2006; 306():199-230. PubMed ID: 16909923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human vaginal fluid contains exosomes that have an inhibitory effect on an early step of the HIV-1 life cycle.
    Smith JA; Daniel R
    AIDS; 2016 Nov; 30(17):2611-2616. PubMed ID: 27536982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications.
    Yarbrough VL; Winkle S; Herbst-Kralovetz MM
    Hum Reprod Update; 2015; 21(3):353-77. PubMed ID: 25547201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secreted mucosal antimicrobials in the female reproductive tract that are important to consider for HIV prevention.
    Ghosh M
    Am J Reprod Immunol; 2014 Jun; 71(6):575-88. PubMed ID: 24754244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships.
    Levinson P; Choi RY; Cole AL; Hirbod T; Rhedin S; Payne B; Guthrie BL; Bosire R; Cole AM; Farquhar C; Broliden K
    PLoS One; 2012; 7(2):e31996. PubMed ID: 22389677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of anti-microbial peptides from rabbit vaginal fluid.
    Patgaonkar M; Aranha C; Bhonde G; Reddy KV
    Vet Immunol Immunopathol; 2011 Feb; 139(2-4):176-86. PubMed ID: 21047689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage form.
    Pattani A; McKay PF; Curran RM; McCaffrey J; Gupta PN; Lowry D; Kett VL; Shattock RJ; McCarthy HO; Malcolm RK
    Vaccine; 2012 Apr; 30(17):2778-85. PubMed ID: 22361120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers.
    Birse KD; Cole AL; Hirbod T; McKinnon L; Ball TB; Westmacott GR; Kimani J; Plummer F; Cole AM; Burgener A; Broliden K
    PLoS One; 2015; 10(6):e0130404. PubMed ID: 26090884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial components of vaginal fluid.
    Valore EV; Park CH; Igreti SL; Ganz T
    Am J Obstet Gynecol; 2002 Sep; 187(3):561-8. PubMed ID: 12237628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible deficiency of antimicrobial polypeptides in bacterial vaginosis.
    Valore EV; Wiley DJ; Ganz T
    Infect Immun; 2006 Oct; 74(10):5693-702. PubMed ID: 16988245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.
    Astronomo RD; Santra S; Ballweber-Fleming L; Westerberg KG; Mach L; Hensley-McBain T; Sutherland L; Mildenberg B; Morton G; Yates NL; Mize GJ; Pollara J; Hladik F; Ochsenbauer C; Denny TN; Warrier R; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Ferrari G; Shaw GM; Xia SM; Liao HX; Montefiori DC; Tomaras GD; Haynes BF; McElrath JM
    EBioMedicine; 2016 Dec; 14():97-111. PubMed ID: 27919754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
    Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.
    Romas LM; Hasselrot K; Aboud LG; Birse KD; Ball TB; Broliden K; Burgener AD
    PLoS One; 2014; 9(6):e100820. PubMed ID: 24978053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.